Drug Type Biological products |
Synonyms AK 2017, AK-2017, AK2017 |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Growth hormone deficiency | Phase 2 | CN | 13 May 2024 | |
Idiopathic short stature | Phase 2 | CN | 13 May 2024 | |
Growth retardation | Phase 1 | CN | 14 Feb 2023 | |
Short Stature, Idiopathic, Autosomal | IND Approval | CN | 05 Dec 2023 |